Beacon Biosignals
Boston, US · Founded 2019 · Delaware corporation · 8 known investors
Find your way into Beacon Biosignals
174 people in our graph share verified history with the Beacon Biosignals team — schools, employers, funds. One of them is your warm intro.
Ben Robbinsunlockedknows Jacob A. Donoghue · together at Harvard Medical School (overlapped)
×7knows the team · via Massachusetts General Hospital
×4knows the team · via Harvard Medical School
Founders & leadership
Beacon Biosignals was founded in 2019 by Jacob A. Donoghue, M.D., Ph.D., Jarrett Revels, and Jacob A. Donoghue.
JA
Jacob A. Donoghue, M.D., Ph.D.Co-founder
JR
Jarrett RevelsinCo-founder · Chief Technology Officer
JA
Jacob A. DonoghueinCo-Founder and CEOJacob A. Donoghue is an executive at Beacon Biosignals, which develops an AI platform that analyzes sleep EEG data for neurological and psychiatric disorders.
Board
CD
Caitlin DonovanBoard director
PR
Pavel RaifeldBoard director
NR
Naveen RaoBoard director
Investors · 8
Catalio Capital Management, LPNew York
.png)
General CatalystSan Francisco · $30Mvia Hemant Taneja · quoted
GV (Google Ventures)Mountain View · $250K – $50M
Iaso VenturesCambridge
Kicker VenturesMenlo Park · $100K – $1Mvia Masashi Kiyomine · inferred
Casdin Capitalreported · 2 sourcesNew York
Indicator VenturesreportedNew York · $1M – $3M
Samsung NextreportedSan Jose · $100K – $5M
Reported raises · per SEC filings
Form D private placements$133.2M disclosed across 3 rounds · 2019–2025
▶$103.3MraisedApr 2026 · 43 investors · Other TechnologyRule 506(b)
▶$103.3MraisedApr 2026 · 43 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Caitlin DonovanDirector
- Pavel RaifeldDirector
- Jacob A. Donoghue, M.D., Ph.D.Executive Officer, Director
- Jarrett RevelsExecutive Officer
- Naveen RaoDirector
- Offering amount
- $103.3M
- Amount sold
- $103.3M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.9MraisedOct 2021 · 42 investors · Other TechnologyRule 506(b)
▶$29.9MraisedOct 2021 · 42 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Naveen RaoDirector
- Jacob A. DonoghueExecutive Officer, Director
- Jarrett RevelsExecutive Officer
- Offering amount
- $29.9M
- Amount sold
- $29.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$50KraisedFeb 2019 · 1 investors · Other TechnologyRule 506(b)
▶$50KraisedFeb 2019 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jacob A. DonoghueExecutive Officer, Director, Promoter
- Naveen RaoDirector
- Jarrett RevelsExecutive Officer, Promoter
- Offering amount
- $1.6M
- Amount sold
- $50K
- Minimum investment
- $10K
- Proceeds to insiders
- $100K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Beacon Biosignals went on to found or lead other companies.
.png)
In the news
Frequently asked questions
- Who founded Beacon Biosignals?
- Beacon Biosignals was founded by Jacob A. Donoghue, M.D., Ph.D., Jarrett Revels, Jacob A. Donoghue in 2019.
- Who are Beacon Biosignals's investors?
- Beacon Biosignals's investors include Catalio Capital Management, LP, General Catalyst, GV (Google Ventures), Iaso Ventures, Kicker Ventures, Casdin Capital, Indicator Ventures, Samsung Next.
- How much funding has Beacon Biosignals raised?
- Beacon Biosignals has disclosed $133.2M raised across 3 rounds.
- Where is Beacon Biosignals headquartered?
- Beacon Biosignals is headquartered in Boston, US.